CA3039233A1 - Compositions comprising hydroxytyrosol and boswellic acid - Google Patents
Compositions comprising hydroxytyrosol and boswellic acid Download PDFInfo
- Publication number
- CA3039233A1 CA3039233A1 CA3039233A CA3039233A CA3039233A1 CA 3039233 A1 CA3039233 A1 CA 3039233A1 CA 3039233 A CA3039233 A CA 3039233A CA 3039233 A CA3039233 A CA 3039233A CA 3039233 A1 CA3039233 A1 CA 3039233A1
- Authority
- CA
- Canada
- Prior art keywords
- hydroxytyrosol
- subject
- composition
- keto
- bodyweight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662403807P | 2016-10-04 | 2016-10-04 | |
| US62/403,807 | 2016-10-04 | ||
| PCT/US2017/028857 WO2018067200A1 (en) | 2016-10-04 | 2017-04-21 | Compositions comprising hydroxytyrosol and boswellic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3039233A1 true CA3039233A1 (en) | 2018-04-12 |
Family
ID=58664857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3039233A Pending CA3039233A1 (en) | 2016-10-04 | 2017-04-21 | Compositions comprising hydroxytyrosol and boswellic acid |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US11241444B2 (https=) |
| EP (2) | EP4623994A3 (https=) |
| JP (4) | JP7079551B2 (https=) |
| CN (2) | CN109789110A (https=) |
| AU (3) | AU2017340126B2 (https=) |
| CA (1) | CA3039233A1 (https=) |
| ES (1) | ES3040765T3 (https=) |
| PL (1) | PL3522874T3 (https=) |
| WO (1) | WO2018067200A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7079551B2 (ja) | 2016-10-04 | 2022-06-02 | ニュートラマックス ラボラトリーズ，インコーポレイテッド | ヒドロキシチロソールおよびボスウェリン酸を有する組成物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6358542B2 (en) | 1999-12-20 | 2002-03-19 | Usana, Inc. | Antioxidant compositions extracted from olives and olive by-products |
| US7713569B2 (en) | 2000-09-01 | 2010-05-11 | Creagri, Inc. | Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof |
| JP3820218B2 (ja) | 2000-09-01 | 2006-09-13 | クレアグリ， インコーポレイテッド | 植物水からヒドロキシチロソール富化組成物を得る方法 |
| CA2474798C (en) | 2002-02-13 | 2012-12-04 | Creagri, Inc. | Method and composition for treatment of inflammation and aids-associated neurological disorders |
| US20030199581A1 (en) | 2002-03-13 | 2003-10-23 | Seligson Allen L. | Boswellin compositions enhanced with 3-beta-acetyl-11-keto-beta-boswellic acid ("AKBA") industrial manufacture and uses |
| EP1582512A1 (en) | 2004-03-31 | 2005-10-05 | Cognis IP Management GmbH | Process for obtaining hydroxytyrosol from olive leaves extracts |
| US7625947B2 (en) | 2004-06-18 | 2009-12-01 | Laila Nutraceuticals | Analogs of 3-O-acetyl-11-keto-β-boswellic acid |
| WO2006020588A1 (en) * | 2004-08-09 | 2006-02-23 | Creagri, Inc. | Olive compositions and methods for treating inflammatory conditions |
| EP2040696B1 (en) * | 2006-07-14 | 2017-01-25 | DSM IP Assets B.V. | Compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| WO2008006582A1 (en) | 2006-07-14 | 2008-01-17 | Dsm Ip Assets B.V. | Compositions comprising magnolol or honokiol and other active agents for the treatment of inflammatory diseases |
| JP2008120716A (ja) | 2006-11-10 | 2008-05-29 | Eisai Food Chemical Kk | 抗炎症剤 |
| KR101682512B1 (ko) * | 2008-09-15 | 2016-12-05 | 라일라 뉴트라슈티칼스 | 보스웰리아 세라타 추출물을 포함하는 상승적인 항-염증 조성물 |
| CN102451428A (zh) * | 2010-10-14 | 2012-05-16 | 中国中医科学院广安门医院 | 可用于治疗类风湿关节炎的中药组合物 |
| WO2014085613A1 (en) * | 2012-11-30 | 2014-06-05 | Mccord Darlene E | Hydroxytyrosol and oleuropein compositions for induction of dna damage, cell death and lsd1 inhibition |
| US10342802B2 (en) | 2016-10-04 | 2019-07-09 | Nutramax Laboratories, Inc. | Compositions comprising hydroxytyrosol and boswellic acid |
| JP7079551B2 (ja) | 2016-10-04 | 2022-06-02 | ニュートラマックス ラボラトリーズ，インコーポレイテッド | ヒドロキシチロソールおよびボスウェリン酸を有する組成物 |
-
2017
- 2017-04-21 JP JP2019516976A patent/JP7079551B2/ja active Active
- 2017-04-21 WO PCT/US2017/028857 patent/WO2018067200A1/en not_active Ceased
- 2017-04-21 CN CN201780061735.7A patent/CN109789110A/zh active Pending
- 2017-04-21 ES ES17720995T patent/ES3040765T3/es active Active
- 2017-04-21 PL PL17720995.4T patent/PL3522874T3/pl unknown
- 2017-04-21 CN CN202510507272.9A patent/CN120241745A/zh active Pending
- 2017-04-21 EP EP25185237.2A patent/EP4623994A3/en active Pending
- 2017-04-21 CA CA3039233A patent/CA3039233A1/en active Pending
- 2017-04-21 AU AU2017340126A patent/AU2017340126B2/en active Active
- 2017-04-21 EP EP17720995.4A patent/EP3522874B1/en active Active
-
2020
- 2020-03-26 US US16/830,454 patent/US11241444B2/en active Active
-
2021
- 2021-12-22 US US17/559,571 patent/US11980624B2/en active Active
-
2022
- 2022-05-19 JP JP2022082301A patent/JP7341596B2/ja active Active
-
2023
- 2023-05-31 AU AU2023203427A patent/AU2023203427B2/en active Active
- 2023-08-25 JP JP2023137408A patent/JP7562225B2/ja active Active
-
2024
- 2024-04-24 US US18/644,758 patent/US20240285648A1/en active Pending
- 2024-09-20 JP JP2024163552A patent/JP2024166415A/ja active Pending
-
2025
- 2025-04-23 AU AU2025202875A patent/AU2025202875A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3522874B1 (en) | 2025-07-02 |
| JP2024166415A (ja) | 2024-11-28 |
| JP2023159387A (ja) | 2023-10-31 |
| JP7562225B2 (ja) | 2024-10-07 |
| JP7341596B2 (ja) | 2023-09-11 |
| AU2023203427B2 (en) | 2025-02-06 |
| ES3040765T3 (en) | 2025-11-04 |
| US20220110946A1 (en) | 2022-04-14 |
| AU2017340126A1 (en) | 2019-04-11 |
| WO2018067200A1 (en) | 2018-04-12 |
| US11241444B2 (en) | 2022-02-08 |
| CN109789110A (zh) | 2019-05-21 |
| US11980624B2 (en) | 2024-05-14 |
| JP2022110125A (ja) | 2022-07-28 |
| AU2017340126B2 (en) | 2023-03-02 |
| JP2019529482A (ja) | 2019-10-17 |
| US20200222424A1 (en) | 2020-07-16 |
| CN120241745A (zh) | 2025-07-04 |
| JP7079551B2 (ja) | 2022-06-02 |
| AU2023203427A1 (en) | 2023-06-29 |
| EP4623994A3 (en) | 2025-11-19 |
| AU2025202875A1 (en) | 2025-05-15 |
| US20240285648A1 (en) | 2024-08-29 |
| EP3522874A1 (en) | 2019-08-14 |
| PL3522874T3 (pl) | 2025-10-06 |
| EP4623994A2 (en) | 2025-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jerosch | Effects of glucosamine and chondroitin sulfate on cartilage metabolism in OA: outlook on other nutrient partners especially Omega‐3 fatty acids | |
| US20250152554A1 (en) | Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration | |
| AU2025202875A1 (en) | Compositions comprising hydroxytyrosol and boswellic acid | |
| US10722524B2 (en) | Compositions comprising hydroxytyrosol and boswellic acid | |
| US20220362172A1 (en) | Novel compositions including cannabis and avocado/soybean unsaponifiables and methods of use | |
| US20200384052A1 (en) | Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration | |
| NZ618389B2 (en) | Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration | |
| HK1236832A1 (en) | Formulation, producing method and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220331 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT Effective date: 20240905 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D00-D149 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S INTERVIEW Effective date: 20240906 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250109 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 8TH ANNIV.) - STANDARD Year of fee payment: 8 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250218 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20250218 Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250218 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250304 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250304 |
|
| D22 | Grant of ip right intended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D22-D128 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALLOWANCE REQUIREMENTS DETERMINED COMPLIANT Effective date: 20250828 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250828 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 9TH ANNIV.) - STANDARD Year of fee payment: 9 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260203 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260203 |